Target Price Playground

MRNA
$223.37
Gamma & Research: Call Wall: $230 (+3.0%) Put Wall: $220 (-1.5%) True IV %ile: 30.5% Flow: BEARISH (40% Bull)
๐ŸŸข
MRNA IV: 71.2% โ€” LOW (-38.8% vs 30d avg of 116.4%)
Options are cheap vs 30d avg โ€” good time to BUY options (long calls/puts, debit spreads).
โšก Quant Efficiency Alert: Bull Call Spread Delivers +332.7% ROI vs -9.4% ROI on Long Call at $250.17 Target
Bull Call Spread cuts entry cost by 79% ($578 vs $2,778), lowers breakeven to $230.78 (+3.3%), and slashes daily theta burn from $24.15/d to $1.08/d.
Switch to Bull Call Spread โ†’

๐Ÿ“‹ Strategy

Bullish. Unlimited upside, capped loss = premium paid.

๐ŸŽฏ Target

1-Click Institutional Target Anchors:
60d from today

โš™๏ธ Legs

LONG CALL ยท $225 ยท Jan '27
Qty 1 ยท Premium $27.78 ยท ฮ” 0.56
P&L at Expiry Now $223 Target $250 $156 $223 $290
Stock (100 sh) Long Call Now Target
๐Ÿ’ก Stock vs Options at Target

If MRNA hits $250 by Jan 15: the long call returns $-261 (-9.4%) on $2,778 risked, vs +$2,680 (12.0%) for 100 shares on $22,337. Options give 0.8ร— capital efficiency.

๐Ÿ“… Expiry & Gamma Wall Alignment

Options expire Jan 15, 2027 (60 days out). P&L shown is the value at expiry if MRNA is at $250.
Tip: For Covered Calls, selling strikes at or above the $230 Call Wall captures dealer overhead resistance; for Cash-Secured Puts, selling at or below the $220 Put Wall aligns with dealer support.

๐Ÿ“Š Projected Return

P&L if MRNA hits $250 by Jan 15
$-261
-9.4% on $2,778 risked
Max Profit
Unlimited
Unlimited upside
Max Loss
โˆ’$2,778
Premium paid
Break-even
$252.78
+13.17% from spot
Prob. of Profit at Expiry (PoP)
29.9%
Above breakeven ($252.78) ยท Touch Target: 70%
30-Day Theta Burn (If Flat)
โˆ’$725
26.1% of entry cost ยท Daily ฮ˜: $-24.15/day
Net ฮ” / ฮ˜ / V
56.23 / -24.15 / 35.69
per spread, per $1 move / day / vol pt
๐Ÿ’พ Log in to save ๐Ÿ“Š My Saved Strategies

๐Ÿ“Š P&L Scenarios โ€” what happens at different prices and dates

MRNA Price Today Dec 6 Dec 26 Jan 15 (exp)
$179 (-20%) -$1,910 -$2,251 -$2,600 -$2,778
$190 (-15%) -$1,549 -$1,957 -$2,422 -$2,778
$201 (-10%) -$1,109 -$1,574 -$2,143 -$2,778
$212 (-5%) -$592 -$1,098 -$1,744 -$2,778
$219 (-2%) -$246 -$769 -$1,445 -$2,778
$223 (0%) โ† spot +$0 -$531 -$1,220 -$2,778
$228 (+2%) +$257 -$280 -$975 -$2,494
$235 (+5%) +$662 +$122 -$573 -$1,824
$246 (+10%) +$1,389 +$855 +$184 -$707
$250 (+12%) โ† target +$1,696 +$1,167 +$514 -$261
$257 (+15%) +$2,174 +$1,657 +$1,036 +$410
$268 (+20%) +$3,010 +$2,520 +$1,962 +$1,526
Uses MRNA's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.